Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
source: pixabay.com
The number of people who have been infected with the coronavirus has now surpassed the SARs virus. Dr. Peter Lin, Director at the Heart Research Center in Canada, questions the…
Continue Reading
Dr. Lin Weighs in on the Controversy of Whether Asymptomatic People Can Spread COVID-19
PRNewswire recently carried BERG’s announcement of the results of its COVID-19 clinical study. BERG, a biotech company based in Framingham, Mass., utilizes artificial intelligence in its research of diseases and…
Continue Reading
BERG Study Identifies a Genetic Factor Responsible For a Disproportionate Number of COVID-19 Cases Among African Americans
Source: Pixabay
PracticeUpdate recently published an article relating to a study with the primary goal of lightening the burden that many males experience regarding long-term prostate surveillance. Active surveillance has been preferred…
Continue Reading
Study Identifies Predictive Tools to Shorten Active Surveillance Required in Prostate Cancer
Healio recently published interviews with members of UCLA’s DRC Health Training and Research Program conducted by Infectious Disease News. Only a few months ago, WHO had announced the end of…
Continue Reading
The End of an Ebola Outbreak Brings New Problems to Survivors
source: pixabay.com
Dr. Jasvinder Singh, a rheumatologist at Alabama’s University in Birmingham is the author of a study that was featured in Arthritis Care and Research. During a recent interview with MedPageToday,…
Continue Reading
Pneumonia Has Been Replaced by Sepsis as the Most Common Serious Infection in Vasculitis Hospitalizations
source: pixabay.com
According to an article in Diagnostic Imaging, MRIs and PET scans show that Parkinson’s disease may start as either body-first or brain-first, in effect behaving like two different diseases.…
Continue Reading
Scientists Confirm That Parkinson’s is Not One, But Two Diseases
source: pixabay.com
Recently, twenty-two year old Jordan Ray of Wellington, Florida spoke with a reporter from The Palm Beach Post, recounting how her life changed in April 2015 during a softball…
Continue Reading
Chiari Malformation Changed This Athlete’s Life Forever
source: pixabay.com
Target RWE, an innovative health evidence solutions company based in Durham, North Carolina recently announced its current data from the study of nonalcoholic steatohepatitis (NASH) via PRNewswire. The study, entitled…
Continue Reading
The TARGET-NASH Study Finds Prior Opioid Use Prevalent in NAFLD Patients
source: pixabay.com
Arrowhead Pharmaceuticals recently announced positive twenty-four-week biopsy results from four patients who participated in the first cohort of the Phase II clinical trial of ARO-AAT. ARO-AAT is Arrowhead’s investigational…
Continue Reading
Patients with Alpha-1 Antitrypsin Deficiency Liver Disease Show Improvement After Six Months of Experimental Treatment
source: pixabay.com
Dr. Naveen Pemmaraju recently interviewed with Targeted Oncology and discussed the many advances in myeloproliferative neoplasms (MPNs) treatment as well as the role of social media during the pandemic.…
Continue Reading
ICYMI: Updates on Myeloproliferative Neoplasms
source: pixabay.com
According to a recent article in Business Wire, it is estimated that five million people in the United States over the age of sixty-five are coping with Alzheimer’s at…
Continue Reading
Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
source: pixabay.com
Dr. Richard Furie at New York’s Feinstein Institutes recently interviewed with MedPage Today. Dr. Furie discussed the prognosis for lupus nephritis and belimumab (Benlysta), a recently-tested drug that appears…
Continue Reading
Belimumab is the Second Drug to be Developed for Lupus in Over Fifty Years
Several decades ago, gene therapy seemed to be on target to treat a disease by simply replacing a defective gene with a healthy one. A recent article republished in APNews…
Continue Reading
CRISPR, The “Genetic Surgeon”
According to a recent article in MedicalXpress, in 2004 Professor Sophie Lucas of the Louvain de Duve Institute began studying immunosuppressive cells that are known to block immune responses in…
Continue Reading
Testing of Immunosuppressive Cells Leads to Tumor Regression
An article that appeared recently in Psychology Today asks whether dementia is responsible for falls. The answer brings to mind the many medical and environmental factors that affect the elderly…
Continue Reading
Dementia Plus Medical and Environmental Factors Often Result in Falls
According to a recent article in Genetic Engineering and Biotechnology News, the neural circuit that is responsible for insomnia has been identified by scientists at the Cold Spring Harbor Laboratory…
Continue Reading
Cold Spring Harbor Scientists Identify Neural Circuit That Causes Insomnia
As reported in Science Daily, researchers at the University of Bristol’s MRC Epidemiology Unit working with pharmaceutical companies have developed an approach to reduce the failure rate of developing drugs.…
Continue Reading
Scientists Develop a New Approach That Reduces the Failure Rate In Drug Development
According to a recent article in MedicalXpress, researchers in Japan led by Dr. Shinsuke Ishigaki and his team at Nagoya University, have identified new molecular details about tau’s activity. Alzheimer’s,…
Continue Reading
Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases
source: pixabay.com
Elliot Preddie, age 12, is ready to get back to his favorite sport, football. He had to put off playing due to sickle cell disease (SCD). Elliot substituted taekwondo and…
Continue Reading
Child With Sickle Cell Disease Received Successful Stem Cell Transplant
Praise Aki Amedal, a Nigerian living in the city of Oriade, has just completed his first book entitled The Biological Prisoner . . . Finding Hope in a Failing Body.…
Continue Reading
A Young Nigerian With a Rare Disease Has Written a Book About His Search for a Cure
source: pixabay.com
Phase III clinical trial results of the triple therapy combination for the treatment of severe aplastic anemia (SAA) were set forth in a recent News Medical Life Sciences article.…
Continue Reading
Severe Aplastic Anemia Patients’ Response Rates Improved with a New Triple Therapy
Ariella Pacheco of Encinitas, California is a 17-year-old in her senior year at a Carmel Valley Catholic School. Ariella spoke to a reporter for MSN about her new-found passion to…
Continue Reading
Special Dolls for Children With Rare Diseases
Business Insider recently interviewed Marissa Oliver, a resident of New York City, who told us about the problems she has encountered during her recovery from COVID-19. Marissa, an arts manager,…
Continue Reading
Researchers Are Investigating a Possible Connection Between Chronic Fatigue Syndrome and COVID-19
A growing wait list is creating additional stress on patients needing organ transplants. These patients are increasingly desperate according to an article recently published in Genetic Engineering & Biotechnology News.…
Continue Reading
One Answer to the Organ Donor Shortage: A Drug That Revitalizes Older Cells
A recent article in Med City News outlines the difficult choices patients must make regarding immune compromising but life-saving therapy during the 2020 pandemic. Do they postpone their treatment or…
Continue Reading
Early Stages of Precision Medicine Being Developed for Cancer Patients During the COVID-19 Pandemic